Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of the Self-management Intervention "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence: A Mixed-Methods Project

NCT01986725 is registered in ClinicalTrials.gov with St.Gallen University of Applied Sciences as lead sponsor.

NCT NCT01986725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01986725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of the Self-management Intervention "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence: A Mixed-Methods Project
Lead sponsor
St.Gallen University of Applied Sciences
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2013
Completion date
November 30, 2015
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vulvar cancer, vulvar intraepithelial neoplasia